Tech Company M&A Transactions
Seragon Pharmaceuticals Acquisition
On 7/2/2014, Seragon Pharmaceuticals was bought by Genentech. The transaction price was $1.7 billion.
Transaction Overview
Company Name
Acquired By
Announced On
7/2/2014
Transaction Type
M&A
Amount
$1,725,000,000
M&A Terms
Under the terms of the agreement, Genentech will make an upfront cash payment of $725 million, plus additional contingent payments of up to $1 billion based on achievement of certain predetermined milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12780 El Camino Real 302
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Seragon Pharmaceuticals is developing small-molecule drugs for the treatment of estrogen receptor dependent breast cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Heyman
Chief Financial Officer
Patricia Millican
Vice President
Nicholas Smith
Browse more venture capital transactions:
Prev: 7/2/2014: Pogoplug venture capital transaction
Next: 7/2/2014: HzO venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs